Prudential Financial Inc Vanda Pharmaceuticals Inc. Transaction History

Prudential Financial Inc

  • $70 Billion
  • Q3 2024

A detailed history of Prudential Financial Inc transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 776,780 shares of VNDA stock, worth $3.96 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
776,780
Previous 777,080 0.04%
Holding current value
$3.96 Million
Previous $4.39 Million 17.02%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$4.61 - $6.34 $1,383 - $1,902
-300 Reduced 0.04%
776,780 $3.64 Million
Q2 2024

Aug 13, 2024
SELL
$3.91 - $6.5 $1.26 Million - $2.09 Million
-321,400 Reduced 29.26%
777,080 $4.39 Million
Q1 2024

May 14, 2024
SELL
$3.47 - $4.61 $1.52 Million - $2.03 Million
-439,300 Reduced 28.57%
1,098,480 $4.51 Million
Q4 2023

Feb 13, 2024
BUY
$3.38 - $4.58 $185,900 - $251,900
55,000 Added 3.71%
1,537,780 $6.49 Million
Q3 2023

Nov 13, 2023
BUY
$4.28 - $6.57 $1.32 Million - $2.02 Million
308,010 Added 26.22%
1,482,780 $6.41 Million
Q2 2023

Aug 11, 2023
BUY
$5.9 - $6.95 $654,079 - $770,483
110,861 Added 10.42%
1,174,770 $7.74 Million
Q1 2023

May 12, 2023
BUY
$6.18 - $7.99 $1.65 Million - $2.14 Million
267,750 Added 33.63%
1,063,909 $7.22 Million
Q4 2022

Feb 14, 2023
BUY
$6.87 - $10.96 $789,569 - $1.26 Million
114,930 Added 16.87%
796,159 $0
Q3 2022

Nov 04, 2022
BUY
$9.44 - $11.76 $1.49 Million - $1.86 Million
157,750 Added 30.13%
681,229 $6.73 Million
Q2 2022

Aug 15, 2022
BUY
$9.31 - $11.84 $118,935 - $151,256
12,775 Added 2.5%
523,479 $5.71 Million
Q1 2022

May 13, 2022
SELL
$10.84 - $16.55 $95,934 - $146,467
-8,850 Reduced 1.7%
510,704 $5.78 Million
Q4 2021

Feb 14, 2022
SELL
$15.69 - $21.14 $2 Million - $2.69 Million
-127,201 Reduced 19.67%
519,554 $8.15 Million
Q3 2021

Nov 15, 2021
SELL
$15.35 - $21.27 $1.91 Million - $2.65 Million
-124,357 Reduced 16.13%
646,755 $11.1 Million
Q2 2021

Aug 16, 2021
SELL
$15.71 - $21.51 $1.67 Million - $2.29 Million
-106,234 Reduced 12.11%
771,112 $16.6 Million
Q1 2021

May 12, 2021
SELL
$13.42 - $20.28 $2.03 Million - $3.06 Million
-151,130 Reduced 14.69%
877,346 $13.2 Million
Q4 2020

Feb 16, 2021
SELL
$9.77 - $13.81 $68,165 - $96,352
-6,977 Reduced 0.67%
1,028,476 $13.5 Million
Q3 2020

Nov 16, 2020
SELL
$9.32 - $12.02 $2.94 Million - $3.79 Million
-315,160 Reduced 23.33%
1,035,453 $10 Million
Q2 2020

Aug 12, 2020
BUY
$9.66 - $12.02 $721,621 - $897,918
74,702 Added 5.85%
1,350,613 $15.5 Million
Q1 2020

May 12, 2020
BUY
$7.5 - $16.8 $76,605 - $171,595
10,214 Added 0.81%
1,275,911 $13.2 Million
Q4 2019

Feb 11, 2020
BUY
$12.38 - $17.47 $3.86 Million - $5.45 Million
311,797 Added 32.69%
1,265,697 $20.8 Million
Q3 2019

Nov 13, 2019
BUY
$12.27 - $15.79 $7.39 Million - $9.51 Million
602,359 Added 171.35%
953,900 $12.7 Million
Q2 2019

Aug 08, 2019
BUY
$13.37 - $18.85 $89,445 - $126,106
6,690 Added 1.94%
351,541 $0
Q1 2019

May 15, 2019
SELL
$17.59 - $31.05 $5.75 Million - $10.1 Million
-326,655 Reduced 48.65%
344,851 $0
Q4 2018

Feb 07, 2019
SELL
$18.97 - $31.47 $2.31 Million - $3.84 Million
-121,996 Reduced 15.37%
671,506 $17.5 Million
Q3 2018

Nov 07, 2018
SELL
$18.25 - $23.0 $670,450 - $844,951
-36,737 Reduced 4.42%
793,502 $0
Q2 2018

Aug 13, 2018
SELL
$13.95 - $19.15 $244,683 - $335,891
-17,540 Reduced 2.07%
830,239 $0
Q1 2018

May 04, 2018
BUY
$14.05 - $20.2 $2.02 Million - $2.9 Million
143,770 Added 20.42%
847,779 $0
Q4 2017

Feb 13, 2018
BUY
$12.85 - $18.1 $1.48 Million - $2.08 Million
115,031 Added 19.53%
704,009 $10.7 Million
Q3 2017

Nov 02, 2017
BUY
$15.4 - $18.85 $9.07 Million - $11.1 Million
588,978
588,978 $10.5 Million

Others Institutions Holding VNDA

# of Institutions
161
Shares Held
45.5M
Call Options Held
150K
Put Options Held
33.6K
View Full List

About Vanda Pharmaceuticals Inc.

VNDA Quotes by TradingView
  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $288M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email